Hepatology Clinical Trials
Theratechnologies plans to initiate a phase 3 clinical trial using tesamorelin for the treatment of NASH.
Further details will be announced as they are finalized.
Theratechnologies plans to initiate a phase 3 clinical trial using tesamorelin for the treatment of NASH.
Further details will be announced as they are finalized.